Recently, a patient centricity concept has spread across all corners of the healthcare community with a straightforward goal: to improve and save patients’ lives through innovative and effective drug therapies adapted to patients’ individual needs. However, for this concept to truly come to life, it is necessary to count on temperature-controlled supply chain logistics like CRYOPDP to turn what could be a complex operation into a highly efficient process. This is extremely vital, because a patient’s life could literally be on the line with every shipment.
 
Patient centricity in the clinical trial community involves meeting the patients where they are.
 
The clinical trial industry is globalising and demands international healthcare logistics partners that can serve its growing and continuously evolving needs. For decades, temperature-controlled logistics experts have operated behind the scenes with patients barely aware of the hard work that went into their medicine’s journey. Thanks to the Covid-19 vaccine distribution’s impressive performance and its universal effect on people’s health across the globe, it has become apparent to the world just how critical and important a logistics provider’s mission is for both patients and the industry.
 
The endless pandemic lockdowns meant that patients could not travel to hospital sites for clinical trials due to travel and access restrictions. This led to a seismic shift where sponsors quickly moved to a direct-to-patient model to try to continue trials and keep patient treatments on schedule. As part of our response to this unique situation, CRYOPDP as a specialist in temperature-controlled logistics, with the mission to improve people’s healthcare options, had to go further and dive deeper to better understand customers’ perceptions of the impact of the pandemic and work with them to provide those options.

With the patient always at the centre of its business and considering the huge development of decentralised clinical trials, the development and implementation of a new service such as Direct-to-Patient seems to be the most natural evolution for CRYOPDP.  We have been offering this turnkey solution completely adapted to patients’ needs, with the same efficiency and total peace of mind, to the benefit of many customers.
 
This model makes life a lot easier for patients and their families, as they don’t have to make multiple trips to a clinic or hospital that is potentially a great distance from their home. It is also beneficial for patients who may be too ill to travel, as well as saves patients’ time and money.
 
Because of these benefits, the direct-to-patient model has increased clinical trial recruitment by up to 60 percent and helped to maintain patient retention by over 95 percent. Drug developers can also gain access to a larger patient population by onboarding those who are not located near participating hospitals or clinics.
 
Patient centricity becomes more evident with the new generation of cell and gene therapies.
 
From day one, CRYOPDP temperature-controlled logistics solutions have always been essential to improve and save patients’ lives. But, when speaking about cell and gene therapies in particular, this gains an even more significant meaning.
 
The increase in personalised medicine, advanced therapies, and improved access to healthcare in the developing world are influencing future supply chain solutions development. Cell and gene therapies are enabling the healthcare community to shift the arrow and think about patients in a whole new way.
 
Cell and gene therapies demand rigorous and precise temperature control to ensure that the therapies maintain their viability. And maintaining temperature control calls for flawless implementation and execution.

From designing the best transportation route to selecting the correct packaging, every detail is critical to keep product integrity high under all conditions, and for this to happen, the healthcare community can count on CRYOPDP specialists who can meticulously handle the entire supply chain process. We’ve been supporting the life sciences and healthcare communities and focused on improving patient centricity with innovative temperature-controlled logistics solutions because thinking about the patient and the outcome of our work is what moves and inspires us to be better every day.

In all the geographies of the world that we cover, around 150 countries, we produce an operational performance of 99.96%.  And to deliver such operational performance, we count on our employees, the specialists around the globe, to follow our quality standards and protocols in detail, so we can deliver a quality service.

When dealing with patients’ lives, there is no room for errors. It’s all about quality of service – making sure that lifesaving samples are distributed on time, within the correct specifications and at the right temperature – to ensure the patient’s health is never compromised.  
 
This commitment has helped CRYOPDP to win numerous industry awards, including ‘Best Clinical Trial Logistics Provider in APAC’ at the Bioprocessing Excellence Awards 2021 and ‘Most Advanced Healthcare Solution Providers from Europe 2021’ by Healthcare Insights Magazine.
 
Our achievements are being recognised across the industry, and as we continue to improve our services for healthcare communities, it will be the end patient that benefits the most.